Relapsing-remitting Multiple Sclerosis (RRMS)

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis

A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis

A Study for Tysabri Participant Preference

MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)

Plegridy Satisfaction Study in Participants

Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®

Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab

Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Brimonidine Tartrate for the Treatment of Injection Related Erythema